Trial Parameters
Brief Summary
Medication adherence is a poorly studied phenomenon that challenges both patients and physicians. 50% of individuals with chronic disease are not adherent to their medication regimen. Within the United States, non-adherence to medical treatment leads to approximately $100 billion in hospital admission costs. While the issue of adherence is not limited to any particular field of medicine, non-adherence occurs in approximately one-third to one-half of dermatological patients. Non-adherence is of importance as it is a significant cause of treatment failure, resulting in worse quality of life, worse health outcomes, and increased insurance costs.
Eligibility Criteria
Inclusion Criteria: * Diagnosis of skin dermatitis * Age \> 9 * Ability to return for a one-week clinical studies follow-up * Patients who are candidates for treatment with 0.1% triamcinolone ointment (even if they weren't in the study) * Adult or pediatric patients with active dermatitis who receive dermatologic care at Atrium Health Wake Forest Baptist, Department of Dermatology. Exclusion Criteria: * Patients without the diagnosis of skin dermatitis * Inability to return for a one week follow up appointment * Body Surface Area (BSA) affected \<2%